Bipolar and schizophrenia risk gene AKAP11 encodes an autophagy receptor coupling the regulation of PKA kinase network homeostasis to synaptic transmission
Results Patients with moderate/severe nutritional risk exhibited significantly higher hospitalization costs than those with no/mild risk, especially during the initial phases of treatment
This is why muscle preservation is important during GLP-1 or medical weight-loss treatment
When muscle mass drops too much: Your metabolism slows down , so you burn fewer calories You lose strength, stability, and energy You may regain fat more easily after stopping the medication You increase your risk of long-term frailty and poor body composition The goal isnt just to lose weight its to lose fat while keeping (or gaining) strength
Overall metabolic health improves GLP-1 medications regulate blood sugar and lower inflammation, acting as a safety signal to your reproductive system
Its compounded semaglutide and tirzepatide preparations are not FDA-approved
